Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models - Arthritis Research & Therapy #JIRSecondaryAntibodies https://t.co/xyhii3EUHQ by @biomedcentral
1,506 followers
96 followers
RT @AlpineImmuneSci: Excited to share a study of ALPN-101, a dual ICOS/CD28 antagonist, published in @ArthritisResTher this week! Study dem…
779 followers
RT @AlpineImmuneSci: Excited to share a study of ALPN-101, a dual ICOS/CD28 antagonist, published in @ArthritisResTher this week! Study dem…
1,803 followers
RT @AlpineImmuneSci: Excited to share a study of ALPN-101, a dual ICOS/CD28 antagonist, published in @ArthritisResTher this week! Study dem…